Martina Verolin of Toleranzia
joined us for World Orphan Drug Congress USA 2015 to present about '
Harnessing the Power of the Immune System'
Download the presentation now to understand more about:
Myasthenia Gravis (MG): an autoimmune neuromusculur disease
Key principal protein components for the treatment of MG
Myasthenia Gravis proof-of-concept studies
Get your copy here!
To find out more about
Toleranzia's unique breakthrough in the treatment of MG
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (4,301Kb in size)